August 2, 2011 – As the 2011 American Association of Physicists in Medicine (AAPM) and Canadian Organization of Medical Physicists (COMP) meet in Vancouver, Canada, GE Healthcare announced the recent U.S. Food and Drug Administration (FDA) clearance and increasing global utilization of its new platform of radiotherapy (RT) planning computed tomography (CT) systems. Highlighted by the Discovery CT590 RT, these CT systems are designed specifically with treatment planning in mind and help physicians address the increasingly specialized imaging needs of patients.

GE’s new wide-bore RT portfolio – including the Discovery CT590 RT and Optima CT580 RT – is dedicated to meeting both current and future clinical oncology demands for diagnostic accuracy, enhanced visualization, complex patient positioning and monitoring, and productive workflow.

Built from the ground up and flexible in a variety of radiation oncology settings, the new RT systems are powered by the latest in GE CT technology. For example, the Discovery CT590 RT offers an automated 4-D video organ motion-recording feature, which captures organ movement to better adapt future radiation therapy treatments.

“As new treatment technologies emerge in radiotherapy, there is an increasing need for intuitive imaging systems supported by robust clinical applications and reliable service,” said Randy Hemingway, administrative director of radiation oncology at Washington Hospital Center in Washington, D.C. “Our new Discovery CT590 RT with Advantage 4-D and Advantage SimMD offer just such benefits – helping us improve workflow with accuracy as we seek optimal clinical outcomes that best meet our patients’ needs.”  

In addition to imaging for oncology, this new family of RT products will also be available for interventional and bariatric CT. In fact, the Discovery CT590 RT can leverage GE’s leading dose reduction technology called ASiR (adaptive statistical iterative reconstruction). This reconstruction technology may enable reduction in pixel noise standard deviation and improvement in low contrast detectability, and may allow for reduced mA in the acquisition of diagnostic images, thereby reducing the dose required. +

+ In clinical practice, the use of ASiR may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.

For more information: www.gehealthcare.com

 

 


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now